Hermetica Superfood Encyclopedia
The Short Answer
Gnetum gnemon leaves and seeds contain a rich array of stilbenoids — including resveratrol, gnetin C, gnetin A, gnemonols E/K/L/M, and oxyresveratrol — that exert antioxidant, cytotoxic, and anti-inflammatory effects by inhibiting cancer-associated molecular targets such as EGFR, mTOR, and SRC. In vitro studies report that the ethyl acetate seed fraction achieves an IC50 of 94.6 µg/mL against MCF-7 breast cancer cells, while the seed rind inhibits angiotensin-converting enzyme (ACE) at an IC50 of 9.77 µg/mL, indicating meaningful antihypertensive potential.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordGnetum gnemon benefits
PNG Gnetum — botanical close-up
Health Benefits
**Antimicrobial and Wound-Healing (Leaves)**
Traditional Papua New Guinean use applies fresh or heated leaves topically to boils and skin infections, leveraging the broad phenolic content of the leaves to inhibit bacterial growth and reduce local inflammation at the site of infection.
**Anticancer Activity (In Vitro)**
Stilbenoid compounds including gnetin A, gnetin C, and resveratrol dimers exhibit cytotoxicity against breast (MCF-7) and prostate cancer cell lines, with the ethyl acetate seed fraction achieving an IC50 of 94.6 µg/mL, attributed to molecular docking interactions with EGFR (−9.90 kcal/mol) and mTOR (−10.70 kcal/mol).
**Antioxidant Protection**
Ethanol seed extracts contain exceptionally high total phenolics (126.154 ± 0.865 mg GAE/g) and flavonoids (44.576 ± 0.611 mg QE/g), conferring strong free-radical scavenging activity with the ethyl acetate fraction showing an IC50 of 160.878 ppm in antioxidant assays.
**Antihypertensive Effects (ACE Inhibition)**
Seed rind extracts inhibit angiotensin-converting enzyme (ACE) with an IC50 of 9.77 µg/mL, suggesting potential utility in cardiovascular health by reducing angiotensin II-mediated vasoconstriction through competitive enzyme inhibition.
**Immune Modulation and NK Cell Enhancement**
Gnetin C has been shown to enhance natural killer (NK) cell cytotoxicity against K562 leukemia cells via upregulation of activating receptors NKG2D and NKp46, pointing to an immunostimulatory mechanism relevant to cancer surveillance.
**Xanthine Oxidase Inhibition (Anti-Gout Potential)**
Rind extracts containing flavonoids, saponins, polyphenols, and alkaloids inhibit xanthine oxidase, the enzyme responsible for uric acid production, suggesting potential benefit in hyperuricemia and gout management.
**Neuroprotective Potential (AChE Inhibition)**
Rind extracts demonstrate acetylcholinesterase (AChE) inhibitory activity, indicating possible relevance to cholinergic neurotransmission support and early-stage neuroprotective applications, though no in vivo or clinical data currently substantiate this use.
Origin & History
Natural habitat
Gnetum gnemon, commonly called melinjo or tulip tree, is native to Southeast Asia and the Pacific Islands, including Papua New Guinea, Indonesia, Malaysia, and the Philippines, where it thrives in humid tropical rainforest environments at low to mid elevations. The plant is a gymnosperm shrub or small tree cultivated around village gardens and forest edges for its edible seeds, leaves, and bark. In Papua New Guinea, it grows abundantly across lowland and foothill forests where traditional communities have harvested its leaves and seeds for generations as both food and medicine.
“Gnetum gnemon has been a staple food and medicinal plant across Papua New Guinea, Indonesia, Malaysia, and the broader Pacific for centuries, with every part of the plant — leaves, seeds, bark, and flowers — utilized in traditional village life. In Papua New Guinea, fresh leaves are a well-documented traditional remedy for boils, applied as a poultice to draw out infection and reduce swelling, representing one of the more specific ethnopharmacological applications recorded in Pacific Islands medicine. In Indonesia, particularly Java and Bali, seeds are processed into emping crackers and incorporated into daily cooking, with the plant historically regarded as a food that also confers vitality and resistance to disease in traditional Javanese medicine. Across Southeast Asian ethnobotanical traditions, the plant is also associated with male fertility, skin health, and anti-aging, though these uses have not been formally documented in peer-reviewed ethnobotanical registries to the extent of the boil remedy.”Traditional Medicine
Scientific Research
The evidence base for Gnetum gnemon consists exclusively of in vitro cell-culture experiments, phytochemical characterization studies, and computational molecular docking analyses; no peer-reviewed human clinical trials have been published as of the current literature search. Key in vitro findings include an IC50 of 94.6 µg/mL for the ethyl acetate seed fraction against MCF-7 breast cancer cells, ACE inhibition at IC50 9.77 µg/mL, and xanthine oxidase inhibition by rind extracts, all conducted without animal or human validation. A gnetin C immunology study demonstrated enhanced NK cell cytotoxicity against K562 cells after two weeks of treatment, but lacks reported sample sizes, statistical power analysis, or controlled blinding. Approximately 149 compounds have been identified across the genus via metabolomics (KNapSAcK database) and Prep-HPLC, providing a solid phytochemical foundation, but the translation of in vitro cytotoxic concentrations to achievable in vivo levels remains undemonstrated, substantially limiting clinical confidence.
Preparation & Dosage
Traditional preparation
**Traditional Leaf Poultice (Papua New Guinea)**
Fresh leaves are bruised, warmed, or directly applied to boils and abscesses; no standardized quantity exists, and application is repeated until lesion resolves.
**Ethanol Seed Extract (Research Grade)**
865 mg GAE/g — no human dose established
Tested in vitro at concentrations ranging from 31.25 to 1000 µg/mL; yields total phenolics of 126.154 ± 0..
**Ethyl Acetate Fraction (Research Grade)**
Most potent antioxidant and cytotoxic fraction in laboratory settings (IC50 160.878 ppm antioxidant; IC50 94.6 µg/mL MCF-7); not available as a commercial supplement.
**Seed as Food (Traditional)**
Seeds are boiled, roasted, or processed into crackers (emping) in Indonesian and Papua New Guinean cuisine — regular dietary consumption represents the most established and safe exposure route.
**Rind Extract (Functional Research)**
Used experimentally for ACE inhibition (IC50 9.77 µg/mL) and xanthine oxidase inhibition; preparation method involves aqueous or ethanol maceration of dried rind material.
**Standardization**
No commercial supplement is currently standardized for stilbenoid content; research preparations are characterized by total phenolics (GAE/g) and flavonoids (QE/g) using spectrophotometric methods.
Nutritional Profile
Gnetum gnemon seeds are nutritionally dense, providing protein (approximately 9–14% by dry weight), complex carbohydrates, and dietary fiber. The seeds contain a unique stilbenoid phytochemical profile with resveratrol, resveratrol dimers (gnetin A, C, D), gnemonols (E, K, L, M), oxyresveratrol, pterostilbene, and ursolic acid as primary bioactives; total phenolics in ethanol seed extracts reach 126.154 mg GAE/g and flavonoids 44.576 mg QE/g. Leaves contribute dietary iron, calcium, and beta-carotene typical of dark tropical greens, alongside phenolic acids and flavonoids. Bioavailability of stilbenoids such as gnemonol E and K is predicted to be poor due to low aqueous solubility, whereas smaller stilbenes like resveratrol and pterostilbene are Lipinski-compliant and more likely to be orally absorbed. The rind contains saponins, alkaloids, and polyphenols in addition to the stilbenoid fraction, contributing to its xanthine oxidase and AChE inhibitory properties.
How It Works
Mechanism of Action
The primary bioactives of Gnetum gnemon — stilbenoids such as gnetin A, gnetin C, resveratrol, gnemonols, and oxyresveratrol — exert anticancer effects through high-affinity molecular docking interactions with key oncogenic kinases and signaling proteins: gnetin A binds EGFR (PDB 1M17) at −9.90 kcal/mol via hydrogen bonding with LYS721, ASP831, and LEU764, while gnetin C and resveratrol dimers bind mTOR (PDB 1FAP) at −10.70 kcal/mol, and (−)-viniferin inhibits SRC kinase (PDB 1Y57) at −9.80 kcal/mol. Antioxidant activity is mediated by the dense polyphenolic matrix — including flavonoids and resveratrol derivatives — which donate electrons to neutralize reactive oxygen species and chelate pro-oxidant metal ions. ACE inhibition by rind polyphenols interrupts the renin-angiotensin system by competitively blocking the conversion of angiotensin I to angiotensin II, reducing peripheral vascular resistance, while xanthine oxidase inhibition by flavonoids and saponins reduces superoxide generation and uric acid accumulation. Gnetin C additionally upregulates NK cell-activating receptors NKG2D and NKp46, enhancing innate immune cytotoxicity through a receptor-mediated immunological mechanism independent of direct cytotoxic action.
Clinical Evidence
No human clinical trials have investigated Gnetum gnemon leaf or seed extracts for any health indication, including the traditional Papua New Guinean use of leaves for boils. The strongest quantitative evidence comes from in vitro studies: MCF-7 cytotoxicity (IC50 94.6 µg/mL), ACE inhibition (IC50 9.77 µg/mL from rind), and antioxidant activity (ethyl acetate IC50 160.878 ppm), all of which provide mechanistic plausibility but not clinical efficacy data. The NK cell gnetin C study, while biologically compelling due to NKG2D/NKp46 upregulation, lacks the methodological rigor required for clinical translation. Overall confidence in therapeutic application is low due to the complete absence of human pharmacokinetic, dose-finding, safety, or efficacy trial data.
Safety & Interactions
No formal toxicology studies, adverse event reports, or clinical safety data exist for Gnetum gnemon leaf or seed extracts used as medicinal preparations; the primary safety reference point is its long history of culinary consumption in Southeast Asia and Papua New Guinea without documented population-level harm. In vitro data indicate cytotoxic activity is selective toward cancer cell lines at tested concentrations, with no noted toxicity in normal cells, and computational ADMET profiles of key stilbenoids suggest favorable safety parameters including Lipinski rule-of-five compliance. Potential drug interactions are theoretically relevant given ACE inhibitory activity — concurrent use with antihypertensive medications (ACE inhibitors, ARBs) could produce additive blood pressure lowering — and xanthine oxidase inhibition could theoretically augment the effects of allopurinol or febuxostat in gout management. No pregnancy or lactation safety data exist, and in the absence of clinical trials establishing safe therapeutic doses, medicinal use beyond traditional dietary consumption should be approached cautiously, particularly in individuals on cardiovascular or immunosuppressive medications.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Gnetum gnemonMelinjoTulip tree (PNG)Bago (Philippines)BelinjoJoint fir (generic Gnetum)
Frequently Asked Questions
How are Gnetum gnemon leaves traditionally used for boils in Papua New Guinea?
In Papua New Guinea, fresh Gnetum gnemon leaves are bruised or gently warmed and applied directly as a poultice over boils and skin abscesses to reduce swelling and draw out infection. This practice leverages the leaf's phenolic and flavonoid content, which confers antimicrobial and anti-inflammatory properties, though this specific application has not been validated in controlled clinical studies.
What are the main bioactive compounds in Gnetum gnemon seeds?
The seeds of Gnetum gnemon are richest in stilbenoid compounds, including trans-resveratrol, resveratrol dimers (gnetin A, gnetin C, gnetin D), gnemonols (E, K, L, M), oxyresveratrol, and pterostilbene, alongside ursolic acid. Ethanol seed extracts also contain high total phenolics (126.154 mg GAE/g) and flavonoids (44.576 mg QE/g), making the seeds the most phytochemically concentrated part of the plant.
Does Gnetum gnemon have anticancer properties?
In vitro laboratory studies show that the ethyl acetate fraction of Gnetum gnemon seeds inhibits MCF-7 breast cancer cell growth with an IC50 of 94.6 µg/mL, while molecular docking analyses demonstrate that gnetin A binds EGFR at −9.90 kcal/mol and gnetin C binds mTOR at −10.70 kcal/mol. However, no human clinical trials have been conducted, so anticancer efficacy in people cannot be confirmed based on current evidence.
Is Gnetum gnemon safe to consume?
Gnetum gnemon has been safely consumed as food across Papua New Guinea, Indonesia, and Southeast Asia for centuries in the form of cooked seeds, leaves, and processed crackers (emping), without documented population-level toxicity. No formal clinical safety studies exist for medicinal extracts, but in vitro data show no toxicity to normal cells at tested concentrations; individuals taking antihypertensive medications should use concentrated extracts with caution due to potential ACE inhibitory activity.
What is gnetin C and why is it significant?
Gnetin C is a resveratrol dimer stilbenoid found in Gnetum gnemon seeds that has attracted research interest for two distinct activities: binding mTOR with a high docking affinity of −10.70 kcal/mol suggesting anticancer potential, and enhancing natural killer (NK) cell cytotoxicity against K562 leukemia cells by upregulating the activating immune receptors NKG2D and NKp46. These dual mechanisms make gnetin C one of the most pharmacologically interesting compounds in the plant, though all evidence remains preclinical.
What is the difference between Gnetum gnemon leaves and seeds for health benefits?
Gnetum gnemon leaves are traditionally used topically for antimicrobial and wound-healing applications, particularly in treating boils and skin infections due to their high phenolic content. The seeds, by contrast, contain concentrated stilbenoid compounds (gnetin A, gnetin C, and resveratrol dimers) that have shown anticancer potential in laboratory studies. While leaves target localized skin issues, seeds are typically consumed orally for systemic benefits, making them functionally complementary plant parts.
Does Gnetum gnemon interact with antibiotic medications?
There is limited clinical research on direct interactions between Gnetum gnemon and antibiotics, though the ingredient's own antimicrobial properties suggest potential additive effects rather than antagonistic ones. Since Gnetum gnemon is traditionally used to support the body's response to bacterial skin infections rather than as a systemic antibiotic replacement, concurrent use with prescribed antibiotics is generally considered complementary. Anyone taking systemic antibiotics should consult a healthcare provider before adding Gnetum gnemon supplements to avoid unexpected synergistic effects.
Is there clinical evidence supporting Gnetum gnemon's use beyond traditional applications?
Most robust evidence for Gnetum gnemon comes from traditional use in Papua New Guinea for topical wound and boil treatment, supported by phytochemical analysis showing antimicrobial phenolics. In vitro (laboratory) studies have demonstrated anticancer potential of its stilbenoid compounds, but human clinical trials remain limited or unpublished. Current research is strongest for traditional antimicrobial applications; anticancer claims require further clinical validation before being considered evidence-based.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w png-gnetum-gnetum-gnemon curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
